Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-01 Sale | 2024-10-03 4:55 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 10,000 | $9.2616 | $92,616 | 181,944 (Direct) | View |
| 2024-10-02 Sale | 2024-10-03 4:55 pm | Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd SVP Chief Commercial Officer | 3,725 | $10.01 | $37,295 | 136,635 (Direct) | View |
| 2024-09-24 Sale | 2024-09-25 9:42 pm | Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer | 11,626 | $9.4843 | $110,264 | 158,374 (Direct) | View |
| 2024-09-03 Sale | 2024-09-05 5:56 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 10,000 | $10.77 | $107,695 | 191,944 (Direct) | View |
| 2024-08-19 Sale | 2024-08-21 4:39 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 1,728 | $8.286 | $14,318 | 194,859 (Direct) | View |
| 2024-08-02 Sale | 2024-08-05 4:37 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks | 5,220 | $9.0161 | $47,064 | 183,288 (Direct) | View |
| 2024-08-02 Sale | 2024-08-05 4:37 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 13,206 | $9.0191 | $119,106 | 196,587 (Direct) | View |
| 2024-08-02 Sale | 2024-08-05 4:37 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 14,487 | $9.0183 | $130,648 | 1,077,403 (Indirect Direct) | View |
| 2024-08-01 Sale | 2024-08-05 4:37 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 10,000 | $9.8696 | $98,696 | 201,944 (Indirect Direct) | View |
| 2024-07-01 Sale | 2024-07-02 7:13 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 10,000 | $9.3141 | $93,141 | 211,944 (Indirect Direct) | View |
| 2024-06-04 Sale | 2024-06-06 4:15 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 10,000 | $8.0092 | $80,092 | 200,872 (Indirect Direct) | View |
| 2024-05-29 Sale | 2024-05-31 4:50 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 72,952 | $8.7277 | $636,706 | 462,793 (Direct) | View |
| 2024-05-28 Sale | 2024-05-29 7:38 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 1,775 | $9.0074 | $15,988 | 188,508 (Direct) | View |
| 2024-05-17 Sale | 2024-05-20 5:12 pm | Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd SVP Chief Commercial Officer | 7,640 | $8.9767 | $68,582 | 140,360 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 4:29 pm | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 4,681 | $8.7378 | $40,902 | 145,505 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 4:22 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 13,783 | $8.7378 | $120,433 | 1,091,890 (Indirect Direct) | View |
| 2024-05-02 Sale | 2024-05-03 4:22 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 5,016 | $8.7378 | $43,829 | 185,408 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 4:22 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 9,555 | $8.7378 | $83,490 | 259,745 (Direct) | View |
| 2024-03-04 Sale | 2024-03-06 5:14 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 3,760 | $11.12 | $41,816 | 190,424 (Direct) | View |
| 2024-03-04 Sale | 2024-03-06 5:12 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 4,782 | $11.12 | $53,182 | 269,300 (Direct) | View |
| 2024-03-04 Sale | 2024-03-06 5:09 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 14,903 | $11.12 | $165,739 | 1,105,673 (Indirect Direct) | View |
| 2024-03-04 Sale | 2024-03-06 5:08 pm | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 3,468 | $11.12 | $38,568 | 146,020 (Direct) | View |
| 2024-03-04 Purchase | 2024-03-06 4:28 pm | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director | 21,052 | $9.5 | $199,994 | 8,817,666 (Indirect Direct) | View |
| 2024-02-28 Sale | 2024-03-01 4:11 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 2,465 | $10.6 | $26,129 | 1,120,576 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-21 Option Award | 2024-09-25 9:42 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer | 60,000 | $0 | 158,374 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-05 4:37 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 6,614 | $0 | 201,944 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-05 4:37 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 6,614 | $1.6806 | 201,944 (Direct) | View |
| 2024-07-01 Exercise | 2024-07-02 7:13 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 10,000 | $0 | 211,944 (Direct) | View |
| 2024-07-01 Exercise | 2024-07-02 7:13 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 10,000 | $1.6806 | 211,944 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 4:52 pm | N/A 2034-06-14 | Arcutis Biotherapeutics Inc. | ARQT | Leonard Keith R Director | 37,191 | $0 | 47,628 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 4:52 pm | N/A 2034-06-14 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 37,191 | $0 | 232,382 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 4:52 pm | N/A 2034-06-14 | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner | 37,191 | $0 | 45,878 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 4:52 pm | N/A 2034-06-14 | Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director | 37,191 | $0 | 45,878 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 4:51 pm | N/A 2034-06-14 | Arcutis Biotherapeutics Inc. | ARQT | Krishnamohan Neha Director | 37,191 | $0 | 42,798 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 4:51 pm | N/A 2034-06-14 | Arcutis Biotherapeutics Inc. | ARQT | LIN SUE-JEAN Director | 37,191 | $0 | 46,178 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 4:51 pm | N/A 2034-06-14 | Arcutis Biotherapeutics Inc. | ARQT | Gilbert Halley E Director | 37,191 | $0 | 45,878 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 4:51 pm | N/A 2034-06-14 | Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director | 37,191 | $0 | 937,250 (Direct) | View |
| 2024-06-04 Exercise | 2024-06-06 4:15 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 10,000 | $0 | 200,872 (Direct) | View |
| 2024-06-04 Exercise | 2024-06-06 4:15 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 10,000 | $1.6806 | 200,872 (Direct) | View |
| 2024-05-30 Exercise | 2024-05-31 4:50 pm | N/A 2034-01-12 | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 23,000 | $0 | 462,793 (Direct) | View |
| 2024-05-27 Option Award | 2024-05-29 7:38 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 4,875 | $0 | 188,508 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-20 5:12 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd SVP Chief Commercial Officer | 60,000 | $0 | 140,360 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 4:29 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 4,166 | $0 | 145,505 (Direct) | View |
| 2024-04-10 Option Award | 2024-04-11 8:32 pm | N/A 2034-04-10 | Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer | 420,000 | $0 | 420,000 (Direct) | View |
Ownership | 2024-04-11 8:30 pm | N/A 2033-12-18 | Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer | 0 | $0 | 7,500 (Direct) | View |
| 2024-02-13 Disposition | 2024-02-15 6:47 pm | N/A 2031-01-19 | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 247,300 | $0 | 149,488 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 6:47 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 68,232 | $0 | 149,488 (Direct) | View |
| 2024-02-13 Disposition | 2024-02-15 6:36 pm | N/A 2030-08-03 | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 451,700 | $0 | 274,082 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 6:36 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 189,050 | $0 | 274,082 (Direct) | View |
| 2024-02-13 Disposition | 2024-02-15 6:32 pm | N/A 2032-01-03 | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 276,100 | $0 | 194,184 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 6:32 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 119,550 | $0 | 194,184 (Direct) | View |
| 2024-02-13 Disposition | 2024-02-15 6:30 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 584,500 | $0 | 1,123,041 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 6:30 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 264,882 | $0 | 1,123,041 (Direct) | View |
| 2024-02-13 Disposition | 2024-02-15 6:23 pm | N/A 2025-03-31 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 34,097 | $0 | 152,757 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 6:23 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 11,365 | $0 | 152,757 (Direct) | View |
| 2024-01-12 Option Award | 2024-01-17 4:35 pm | N/A 2034-01-12 | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 304,000 | $0 | 361,032 (Direct) | View |